DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice. (Q55036231)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

0 references

Leishmania major

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Marcos Timón

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

L López-Fuertes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

A J Vila-Coro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

F Sack

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

S Moreno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

S A Konig

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

C Junghans

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

B Wittig

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

M Esteban

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

language of work or name

English

0 references

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

number of pages

11

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

247-257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

The regulation of immunity to Leishmania major

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Regulation of immunity to parasites by T cells and T cell-derived cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Genetic vaccination against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Expression cloning of a protective Leishmania antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Resistance to Leishmania major induced by tolerance to a single antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

1 reference

7 January 2021

Gene vaccination: plasmid DNA is more than just a blueprint

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Applications of pox virus vectors to vaccination: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Mechanisms of nuclear import and export that control the subcellular localization of class II transactivator

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900450-4

7 January 2021

10.1016/S0264-410X(02)00450-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12450700%20AND%20SRC:MED&resulttype=core&format=json

release_kcw4nnpi7fg7hfenybfnip7zhe

15 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kcw4nnpi7fg7hfenybfnip7zhe

24 November 2022

mapped directly with Wikidata item

1 reference